share_log

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $10

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $10

Craig-Hallum维持对ironwood医药的买入评级,将目标价下调至10美元。
Benzinga ·  08/09 12:17  · 评级/大行评级

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price target from $14 to $10.

Craig-Hallum分析师Chase Knickerbocker推荐买入ironwood医药(纳斯达克代码:IRWD),并将目标股价从14美元下调至10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发